Anti-N-methyl-D-aspartate Receptor (NMDAR) Encephalitis (ANRE)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Anti-N-methyl-D-aspartate Receptor (NMDAR) Encephalitis (ANRE) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingPhase 2

NCT07093333

A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease

This study will evaluate the safety, tolerability, preliminary efficacy and pharmacokinetics (PK) of ART5803 in adult participants with a confirmed diagnosis of…

Location not specified30 participantsStarted 2026-05-15

Treatment: ART5803, ART5803-Cohort D